Why Defiance Daily Target 2X Long ORCL ETF (ORCX) Is Up +52% in the Last 30 Days
Key Takeaways
- ORCX rose roughly 52% over the trailing 30 days, tracking approximately two times the daily price moves of Oracle Corporation (ORCL).
- The fund is a leveraged single-stock ETF that targets 200% (2X) daily exposure to Oracle, using swap contracts and options rather than direct share ownership.
- Over the same window, Oracle shares rebounded about 26% as falling Treasury yields and a new cloud partnership with Amazon (AMZN) improved investor sentiment.
- For the trailing quarter, ORCX was down roughly 51%, reflecting Oracle's sharp June selloff tied to capital-spending and cash-burn concerns.
- Principal risks include daily-reset compounding, single-issuer concentration, and Oracle's heavy AI infrastructure spending and rising leverage.
Defiance Daily Target 2X Long ORCL ETF (ORCX) Overview and Portfolio Exposure
The Defiance Daily Target 2X Long ORCL ETF (ORCX) is a leveraged single-stock exchange-traded fund (ETF) that seeks daily investment results corresponding to two times (200%) the daily performance of Oracle Corporation. It was launched in February 2025 by Defiance ETFs, with Tidal Investments serving as investment adviser, and carries an expense ratio of approximately 1.36%. The fund held roughly $269 million in assets under management (AUM), a modest footprint typical of single-stock leveraged products.
Because the fund cannot directly hold two times the notional value of Oracle shares, it obtains its exposure through total-return swaps and options on Oracle's common stock. Its reported portfolio therefore consists of only three underlying positions: a large cash allocation, short-term U.S. Treasury bills, and a government money-market fund. This structure means ORCX's returns are driven almost entirely by Oracle's share-price action, amplified by daily leverage and subject to the compounding effects of daily rebalancing.
ORCX Price Performance: Last 30 Days vs. Quarter
Over the trailing 30 days, ORCX advanced approximately 52%, reflecting a rebound in Oracle's stock from a multi-month low. The move was trend-driven rather than gradual, with the fund climbing off a July trough as Oracle shares recovered. For the trailing quarter, however, the picture is materially different: ORCX declined roughly 51%, underscoring the elevated volatility inherent in a 2X daily-leveraged single-stock product.
The divergence between the two time frames illustrates how daily compounding can produce results that diverge from a simple two-times multiple over longer holding periods. A sharp drawdown followed by an equally sharp recovery leaves a leveraged fund well below its starting point even when the underlying security partially recovers, a structural feature investors should understand before holding ORCX for more than a single trading session.
What Drove ORCX Price in the Last 30 Days
The recent advance in ORCX is almost entirely a reflection of Oracle's own share-price recovery. Over the same 30-day window, Oracle shares rose about 26%, moving from the low $115 area to the mid-$140s. Because ORCX seeks two times daily exposure, that underlying move translated into a leveraged gain of roughly 52% for the fund.
Two factors supported Oracle's rebound. First, a decline in longer-dated U.S. Treasury yields eased the financing pressure on Oracle's debt-funded data-center buildout, making its capital-intensive AI strategy appear more affordable. Second, Oracle and Amazon Web Services announced an expansion of their partnership, making Oracle's Exadata Database Service generally available on AWS's Exascale infrastructure across multiple regions—a development that reinforced Oracle's multi-cloud growth narrative and its positioning in enterprise AI infrastructure.
Broader mega-cap technology sentiment also improved during the period, with investors rotating back into large software and cloud names after a period of AI-related de-risking. Still, Oracle's rebound remained uneven, and ORCX's daily moves were amplified by both the fund's leverage and the high single-name volatility of Oracle's stock.
What Drove ORCX Performance Over the Last Quarter
The trailing quarter tells a more cautionary story. Oracle entered the period after an exceptionally strong May, during which its shares surged on enthusiasm around its rapidly expanding artificial-intelligence order backlog. That momentum reversed sharply in June following Oracle's fiscal fourth-quarter results. Although the company reported revenue growth of 21%, a 93% jump in cloud infrastructure revenue, and a record $638 billion in remaining performance obligations (RPO)—contracted revenue not yet recognized—investors focused instead on the cost of that growth.
Oracle disclosed roughly $70 billion in planned capital expenditures for fiscal 2027, negative free cash flow (FCF) of about $23.7 billion for fiscal 2026, and plans to raise around $40 billion through a combination of debt and equity. A credit-rating downgrade, concerns about customer concentration tied to OpenAI, and broader worries about AI infrastructure spending compounded the selling pressure, sending Oracle shares down roughly 35% in June and driving ORCX substantially lower. The fund's 2X leverage magnified that decline before the late-July and August recovery took hold.
AI Screener
For investors seeking to identify securities with comparable or contrasting characteristics, Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that scans thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. It allows users to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening, and to customize searches around the same momentum and volatility factors that drive leveraged products like ORCX. Explore the AI Screener to build data-driven watchlists tailored to your own investment criteria.
ORCX ETF Outlook: What Investors Should Watch Next
Because ORCX is a daily-leveraged single-stock product, its outlook is inseparable from Oracle's fundamentals and the market's appetite for AI infrastructure. The most important near-term catalyst is Oracle's next quarterly earnings report, where investors will assess whether the company can convert its record backlog into revenue at acceptable margins while managing rising interest costs.
Macroeconomic conditions remain central. The path of Treasury yields and the Federal Reserve's interest-rate stance will influence both Oracle's financing costs and the valuation of long-duration technology assets. Inflation trends and any shift in monetary-policy expectations could therefore amplify moves in ORCX through their effect on Oracle's share price.
Investors should also monitor Oracle's capital-spending execution, free cash flow trajectory, and progress on the AWS and other multi-cloud partnerships, as well as any developments affecting its largest AI customers. Given the fund's leverage and single-issuer concentration, volatility is likely to remain elevated, and holding periods beyond a single day can produce results that differ significantly from two times Oracle's cumulative return.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ORCX in upward trend: price rose above 50-day moving average on September 02, 2026
ORCX moved above its 50-day moving average on September 02, 2026 date and that indicates a change from a downward trend to an upward trend. In 5 of 5 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The 10-day moving average for ORCX crossed bullishly above the 50-day moving average on August 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +11.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCX advanced for three days, in 75 of 80 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 16 of 16 cases where ORCX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on September 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORCX as a result. In 18 of 18 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
ORCX broke above its upper Bollinger Band on September 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ORCX entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.